Skip to content
Tarsons Products logo

Tarsons Products

TARSONS NSE
₹311.10 No trade today
P/E
148.85
View as Markdown
MCP
Close 4 Nov 2026 ₹311.10 +29.25 +10.4% 1Y
Start ₹281.85

Key Fundamentals

MicrocapHealthcare Equipment & SuppliesHealthcare

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
4.59%
Debt to Equity
0.62
EPS (TTM)
₹2.09
Book Value
₹119.29
Market Cap
—
P/E (TTM)
148.85
P/B
2.61
ROE
2.44%
Dividend Yield
0.67%
EBITDA
₹142 Cr
52W High
₹375.00
52W Low
₹164.45
Volume
0

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

59 Good

Data confidence 98/100

Category scores

Quality
65
Good
Returns, margins, earnings quality 22% weight
Valuation
49
Average
Cheap vs sector & own history 24% weight
Growth
39
Weak
Sales & profit trajectory 9% weight
Financial Health
23
Poor
Solvency, leverage, coverage 9% weight
Momentum
68
Strong
Trend strength, vol-adjusted 12% weight
Ownership
81
Strong
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

No strengths listed

Weaknesses

5
  • Stock is trading at 2.52 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 4.68% over last 3 years.
  • Company might be capitalizing the interest cost

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish667
OscillatorsBearish360
Moving AveragesStrong Bullish307

Key readings

RSI (14)
49.20
Neutral
MACD (12,26,9)
−7.55
Bearish
SMA (50)
322.99
Bearish
SMA (200)
256.32
Bullish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
5Y+13.06%
3YIrregular period
1Y+7.91%
TTM+10.63%

Net profit

Net profit growth by window
5Y−27.31%
3YIrregular period
1Y−53.33%
TTM−59.68%

Operating cash flow

Operating cash flow growth by window
5Y+11.65%
3YIrregular period
1Y+3.51%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
5Y−17.08 pp
3YIrregular period
1Y−0.42 pp
TTM−2.23 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2021₹229 Cr
Mar 2022₹301 Cr
Mar 2024₹296 Cr
Mar 2025₹392 Cr
Mar 2026₹423 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2021₹69.00 Cr
Mar 2022₹101 Cr
Mar 2024₹43.00 Cr
Mar 2025₹30.00 Cr
Mar 2026₹14.00 Cr

Quarterly Results

₹ Cr
TARSONS quarterly results, ₹ crore
Particulars Dec 2021Mar 2022Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
70.66
84.94
61.79
106
84.8
99.25
95.68
113
91.36
102
108
121
110
Expenses
37.52
40.61
38.91
75.48
66.04
73.94
66.04
75.67
66.66
74.88
76.37
86.66
84.25
Operating Profit
33.14
44.33
22.88
30.24
18.76
25.31
29.64
37.02
24.7
27.45
31.52
34.27
25.99
OPM %
46.9%
52.19%
37.03%
28.6%
22.12%
25.5%
30.98%
32.85%
27.04%
26.82%
29.21%
28.34%
23.58%
Other Income
2.46
2.58
3.24
3.38
2.91
8.43
0.85
3.78
3.34
5.8
7.07
6.83
5.98
Interest
1.37
0.45
2.51
4.25
4.32
4.84
5.03
5.2
5.07
5.18
6.05
6.25
6.27
Depreciation
5.35
7.24
10.06
12.33
11.03
14.03
17.41
20.03
19.94
22.48
25.04
29.08
27.02
PBT
28.88
39.22
13.55
17.04
6.32
14.87
8.05
15.57
3.03
5.59
7.5
5.77
−1.32
Tax %
25.66%
24.89%
26.72%
39.5%
36.39%
30.8%
34.66%
34.49%
41.25%
40.61%
32.93%
27.56%
9.09%
Net Profit
21.47
29.46
9.93
10.32
4.02
10.29
5.26
10.2
1.78
3.32
5.04
4.18
−1.44
EPS (₹)
4.04
5.54
1.87
1.94
0.76
1.93
0.99
1.92
0.33
0.62
0.95
0.79
−0.27

Profit & Loss

₹ Cr
TARSONS profit and loss, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2024Mar 2025Mar 2026TTM
Sales
229
301
296
392
423
441
Expenses
125
148
196
282
304
322
Operating Profit
103
153
100
111
118
119
OPM %
45%
51%
34%
28%
28%
27%
Other Income
5
8
11
16
24.17
26
Interest
3
4
10
20
23
24
Depreciation
14
22
40
62
97
104
PBT
92
135
61
45
22
18
Tax %
25%
25%
30%
34%
35%
—
Net Profit
69
101
43
30
14
11
EPS (₹)
12.99
18.92
8.01
5.6
2.69
2.09
Div. Payout %
0%
0%
25%
0%
0%
—

Balance Sheet

₹ Cr
TARSONS balance sheet, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2024Mar 2025Mar 2026
Equity Capital
0.19
11
11
11
11
Reserves
244
479
602
620
624
Borrowings
34
22
269
339
393
Other Liabilities
18
33
90
111
158
Total Liabilities
296
544
972
1,080
1,186
Fixed Assets
120
189
336
536
733
CWIP
22
32
267
233
159
Investments
0
0
0
0
0
Other Assets
153
323
369
311
295
Total Assets
296
544
972
1,080
1,186

Cash Flow

₹ Cr
TARSONS cash flow, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2024Mar 2025Mar 2026
Operating
68
83
103
114
118
Investing
−64
−138
−285
−145
−129
Financing
−27
130
136
39
9
Net Cash Flow
−23
75
−47
8
−2
Free Cash Flow
6
−48
−81
−37
−7
CFO/EBITDA
89
77
121
117
107

Ratios

TARSONS financial ratios, annual
Particulars Mar 2021Mar 2022Mar 2024Mar 2025Mar 2026
Debtor Days
75
79
96
74
74
Inventory Days
277
478
572
355
341
Days Payable
35
75
65
44
53
Cash Conversion Cycle
317
482
602
385
361
Working Capital Days
108
150
−1
38
−20
ROCE %
—
35%
—
7%
5%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Tarsons Products insights

69 extracted metrics across FY20–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 47.30%
  • Others 29.99%
  • Public 21.55%
  • DIIs 0.61%
  • FIIs 0.55%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Tarsons Products

What does Tarsons Products Ltd do?
Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical…
Where is Tarsons Products Ltd (TARSONS) listed?
Tarsons Products Ltd trades as TARSONS on the NSE and under code 543399 on the BSE.
Which sector does Tarsons Products Ltd belong to?
Tarsons Products Ltd is classified under the Healthcare sector, in the Medical Equipment industry.
What is the PE ratio of Tarsons Products Ltd?
Tarsons Products Ltd trades at a PE ratio of 148.85 as of 4 Nov 2026, on earnings per share of ₹2.09, against a book value of ₹119.29 per share.
What is the 52-week high and low of Tarsons Products Ltd?
Over the last 52 weeks Tarsons Products Ltd has traded between ₹164.45 and ₹375 as of 4 Nov 2026.
Does Tarsons Products Ltd pay dividends?
Tarsons Products Ltd has a dividend yield of 0.67%.
What is the Return on Equity (ROE) of Tarsons Products Ltd?
Tarsons Products Ltd reported a return on equity of 2.44%. Its debt-to-equity ratio is 0.62.

Company Information

Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals

Website tarsons.com
Listed 26 Nov 2021
Face Value ₹2

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/TARSONS.md for Tarsons Products Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Healthcare Equipment stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month